Aldatu Biosciences

The power of PANDAA qDx: tackling drug resistance with diagnostics innovation. Improving individual & population health while decreasing system costs.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Boston, MA, USA
  • Currency USD
  • Founded January 2014
  • Employees 7
  • Incorporation Type C-corp
  • Website aldatubio.com

Company Summary

Our proprietary genotyping platform technology, PANDAA qDx, overcomes the technical challenges associated with the development of sensitive and accurate diagnostics for complex infectious diseases. PANDAA qDx uniquely enables qPCR - a gold-standard molecular diagnostic technology - for new disease indications like HIV drug resistance. PANDAA qDx testing products will be the first scalable HIVDR testing solutions for emerging markets.

Team

Advisors

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free